update cv + fix typo

singlesp · Nov 4, 2023 · c50dcd0 · c50dcd0
1 parent 806e2ca
commit c50dcd0
Show file tree

Hide file tree

Showing 2 changed files with 1 addition and 1 deletion.
diff --git a/cv.pdf b/cv.pdf
diff --git a/research.html b/research.html
@@ -56,7 +56,7 @@ <h2>Publications</h2>
                     <img src="images/fs2023.png" alt="abstract image">
                     <figcaption><b>Simplified study design.</b> Subjects were assessed and imaged at the start of the study (baseline). All subjects [low dose (LD; 30 mg MDMA), medium dose (MD; 75 mg MDMA), and high dose (HD; 125 mg MDMA)] underwent three non-drug preparatory therapy sessions prior to their first MDMA dosing session. Each MDMA session was followed by three non-drug integration therapy sessions. After MDMA session 2 and the subsequent integration sessions, subjects were assessed and the dosing blind was broken. HD subjects completed their final set of drug and non-drug therapy sessions unblinded, and LD/MD subjects crossed over into the HD arm where they completed three sets of drug and non-drug sessions, now with the higher dose and unblinded. All subjects were assessed and underwent MRI approximately two months following their last HD MDMA session.</figcaption>
                 </figure>
-              <p>[4] <b>S. P. Singleton</b>, J. B. Wang, M. Mithoefer, C. Hanlon, M. S. George, A. Mithoefer, O. Mithoefer, A. R Coker, B. Yazar-Klosinski, A. Emerson, R. Doblin, A. Kuceyeski. (2023). "Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder”. <em>Fronties in Psychiatry</em>, DOI: <a href="https://www.frontiersin.org/articles/10.3389/fpsyt.2022.947622/full" target="_blank">10.3389/fpsyt.2022.947622</a>. Open Access.</p>
+              <p>[4] <b>S. P. Singleton</b>, J. B. Wang, M. Mithoefer, C. Hanlon, M. S. George, A. Mithoefer, O. Mithoefer, A. R Coker, B. Yazar-Klosinski, A. Emerson, R. Doblin, A. Kuceyeski. (2023). "Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder”. <em>Frontiers in Psychiatry</em>, DOI: <a href="https://www.frontiersin.org/articles/10.3389/fpsyt.2022.947622/full" target="_blank">10.3389/fpsyt.2022.947622</a>. Open Access.</p>
             </section>
             <section class="publication">
                 <figure>